Healthcare Services

Eye infections market forecast through 2030

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Eye Infections Market Progress Between 2026 And 2030?

The eye infections market size has experienced significant expansion in recent years. It is anticipated to expand from $7.93 billion in 2025 to $8.36 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.4%. Historically, this growth can be ascribed to a high occurrence of conjunctivitis and keratitis, the growing use of contact lenses, an increase in urban pollution, enhanced healthcare access, and the proliferation of ophthalmology clinics.

The market for eye infections is anticipated to experience robust expansion in the coming years. It is projected to reach $10.24 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.2%. This expansion during the forecast period is driven by factors such as the creation of new antimicrobial eye medications, a growing elderly demographic, an increase in digital eye strain incidents, enhanced availability of ophthalmic care, and the proliferation of online pharmacies. Key trends anticipated for this period encompass a rise in bacterial and viral eye infection cases, a greater uptake of prescribed eye medications, heightened understanding of prompt diagnosis and therapy, the broadening of online and physical pharmacy networks, and the introduction of wide-ranging ophthalmic treatments.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/eye-infections-global-market-report

Which Key Drivers Are Affecting The Eye Infections Market Development?

The rising occurrence and widespread presence of eye conditions are anticipated to propel the eye infections market. These disorders encompass various ophthalmic conditions, including illnesses like glaucoma, cataracts, and macular degeneration, alongside refractive issues such as myopia and hyperopia. An escalating patient count for eye-related ailments stems from factors including demographic shifts towards older populations, evolving lifestyles, environmental influences, and insufficient diagnostic tools causing delays in identifying issues. Eye infections may facilitate the onset or intensification of existing eye conditions through inducing inflammation, harming tissues, and compromising the eye’s inherent protective mechanisms, potentially resulting in adverse outcomes like vision impairment or persistent health problems. For example, data from October 2024, provided by the World Health Organization, a Switzerland-based health authority, indicated that in 2023, 130,746 people received surgical intervention for advanced trachoma, and 32.9 million were given antibiotics, achieving a global coverage of 29%. Consequently, the growing frequency and prevalence of ophthalmic disorders are projected to stimulate growth in the eye infections market in the foreseeable future.

How Is The Eye Infections Market Segmented Across Different Segment Categories?

The eye infections market covered in this report is segmented –

1) By Indications: Conjunctivitis, Keratitis, Endophthalmitis, Blepharitis, Stye, Uveitis, Cellulitis, Ocular Herpes

2) By Drug Type: Corticosteroids, Quinolone Antibiotics, Macrolide Antibiotics, Tetracycline Antibiotics, Polyene Antifungals

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Conjunctivitis: Bacterial Conjunctivitis, Viral Conjunctivitis, Allergic Conjunctivitis

2) By Keratitis: Bacterial Keratitis, Viral Keratitis, Fungal Keratitis, Acanthamoeba Keratitis

3) By Endophthalmitis: Post-surgical Endophthalmitis, Post-traumatic Endophthalmitis, Endogenous Endophthalmitis

4) By Blepharitis: Anterior Blepharitis, Posterior Blepharitis

5) By Stye: Internal Stye, External Stye

6) By Uveitis: Anterior Uveitis, Intermediate Uveitis, Posterior Uveitis, Panuveitis

7) By Cellulitis: Periorbital Cellulitis, Orbital Cellulitis

8) By Ocular Herpes: Herpes Simplex Keratitis, Herpes Simplex Conjunctivitis

What Trends Are Transforming The Eye Infections Market?

Major companies in the eye infections market are prioritizing the development of innovative therapies like photodynamic therapy to improve treatment efficacy and lessen side effects. Photodynamic therapy is a medical approach that employs a light-sensitive drug, which is activated by specific light wavelengths, to identify and eradicate abnormal or infected cells. For example, in December 2024, VisiRose Inc., a US-based clinical-stage biotechnology company, joined forces with Provectus Biopharmaceuticals Inc., a US-based pharmaceutical company, and Bascom Palmer Eye Institute, a US-based health center, to launch Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT). This groundbreaking, non-invasive investigational treatment is intended for infectious keratitis and other serious eye infections. The RB PDAT represents a promising solution to the growing global problem of antimicrobial resistance (AMR) by offering a broad-spectrum ocular treatment. This therapy is designed to be safe, effective, and cost-efficient, thereby addressing the urgent demand for new treatments in this domain.

Which Organizations Play A Role In The Eye Infections Market Landscape?

Major companies operating in the eye infections market are Pfizer Inc, F. Hoffmann-La Roche AG, Merck And Co Inc, AbbVie Inc., Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co Ltd, Regeneron Pharmaceuticals Inc, Alcon Laboratories Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Santen Pharmaceuticals Co Ltd, Rohto Pharmaceutical Co Ltd, Alembic Pharmaceuticals Limited, Novaliq GmbH, Eyevance Pharmaceuticals LLC, Ocular Therapeutix, I-Med Pharma Inc., EyeGate Pharmaceuticals Inc

Get The Full Eye Infections Market Report:

https://www.thebusinessresearchcompany.com/report/eye-infections-global-market-report

Which Geographic Region Dominates The Eye Infections Market?

North America was the largest region in the eye infections market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the eye infections market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Eye Infections Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/eye-infections-global-market-report

Browse Through More Reports Similar to the Global Eye Infections Market 2026, By The Business Research Company

Anemia And Other Blood Disorder Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

Ocular Inflammation Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/ocular-inflammation-treatment-global-market-report

Veterinary Eye Care Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-eye-care-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795